Ligand

About Ligand

Ligand-owned, Captisol® was invented in 1990 by scientists at the University of Kansas Higuchi Biosciences Center for use in drug development and formulation.

The Captisol® technology is used to address the limitations of currently marketed drugs. FDA-approved, Captisol-enabled® medications are marketed by: Pfizer, Bristol-Myers Squibb and Baxter International. Captisol® also has Licens...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • US
  • 2017
    On CPHI since
Company types
Contract Service
View company profile
Contact info
  • (858) 550-7895
  • 2029 Becker Drive, Suite 217, Lawrence, KS, United States
Show contact info Hide contact info

Products from Ligand (1)

  • Captisol

    Product Captisol

    Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of active pharmaceutical ingredients (APIs).



Ligand Resources (1)